ReviewFrontiers in microbiology2024
Pharmaceutically active micropollutants: origin, hazards and removal.
Review in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 42 citations in OpenAlex.
- Visible-light-driven photocatalytic degradation of diclofenac in water by nanoparticulate CuScientific reports · 2026Article
- External Microplastic Filters for Washing Machines: Advances, Technical Challenges, and Biofouling Mitigation.Membranes · 2026Review
- Acyclic cucurbituril as sequestrant for acetaminophen.Chemical communications (Cambridge, England) · 2026Article
- Comparative performance of non-white rot fungal stirred-tank and biofilm-based bioreactors for pharmaceutical wastewater treatment: kinetic modelling and scalability potential.Biodegradation · 2026Article
- Recent advances in lignin-based carbon materials for pollutant removal and oil-water separation: a review.RSC advances · 2026Review
- Hydrothermal Conversion of Annatto Seed Waste (Molecules (Basel, Switzerland) · 2026Article
- Review
- Stimulation of Human Adenovirus Infection Modulated by Emerging Micropollutants.Food and environmental virology · 2026Article
- Citric acid-functionalized graphene oxide membranes with enhanced stability and permeability for high-efficiency separation.iScience · 2026Article
- Plant chloroplasts enable high-yield and cost-effective production of the engineered bacterial enzyme CueO-MacHis as a technical protein via transient expression inFrontiers in plant science · 2026Article
- Knowledge, attitudes, and practices of drug disposal in the United Arab Emirates.Journal of public health research · 2026Article
- Chinese pharmacy students' knowledge, attitudes and practice about environmental risks of pharmaceuticals and their source control from the perspective of One Health.Frontiers in public health · 2026Article
- Micropollutants and Their Interactions With Relevant Environmental Viruses.Environmental microbiology · 2025Review
- Enhanced biodegradation of fluorinated pharmaceutical by Aspergillus flavus and Cunninghamella elegans biofilms: kinetics and mechanisms.Biodegradation · 2025Article
- Microfluidic Sensors for Micropollutant Detection in Environmental Matrices: Recent Advances and Prospects.Biosensors · 2025Review
- Recent Advances in Molecularly Imprinted Polymers and Emerging Polymeric Technologies for Hazardous Compounds.Polymers · 2025Article
- Adaptive responses ofFrontiers in bioengineering and biotechnology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceuticals, recognized for their life-saving potential, have emerged as a concerning class of micropollutants in the environment. Even at minute concentrations, chronic exposure poses a significant threat to ecosystems. Various pharmaceutically active micropollutants (PhAMP), including antibiotics, analgesics, and hormones, have been detected in underground waters, surface waters, seawater, sewage treatment plants, soils, and activated sludges due to the absence of standardized regulations on pharmaceutical discharge. Prolonged exposureof hospital waste and sewage treatment facilities is linked to the presence of antibiotic-resistant bacteria. Conventional water treatment methods prove ineffective, prompting the use of alternative techniques like photolysis, reverse osmosis, UV-degradation, bio-degradation, and nano-filtration. However, commercial implementation faces challenges such as incomplete removal, toxic sludge generation, high costs, and the need for skilled personnel. Research gaps include the need to comprehensively identify and understand various types of pharmaceutically active micropollutants, investigate their long-term ecological impact, develop more sensitive monitoring techniques, and explore integrated treatment approaches. Additionally, there is a gap in understanding the socio-economic implications of pharmaceutical pollution and the efficacy of public awareness campaigns. Future research should delve into alternative strategies like phagotherapy, vaccines, and natural substance substitutes to address the escalating threat of pharmaceutical pollution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.